Galmed Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.

About GLMD

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. 

CEO
Allen J. Baharaff
CEOAllen J. Baharaff
Employees
6
Employees6
Headquarters
Ramat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded
2000
Founded2000
Employees
6
Employees6

GLMD Key Statistics

Market cap
3.51M
Market cap3.51M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
66.32K
Average volume66.32K
High today
High today
Low today
Low today
Open price
$0.658
Open price$0.658
Volume
0.00
Volume0.00
52 Week high
$3.50
52 Week high$3.50
52 Week low
$0.59
52 Week low$0.59

Stock Snapshot

With a market cap of 3.51M, Galmed Pharmaceuticals(GLMD) trades at $0.60. The stock has a price-to-earnings ratio of -0.17.

On 2026-02-13, Galmed Pharmaceuticals(GLMD) stock opened at $0.66, reached a high of —, and a low of —.

Galmed Pharmaceuticals(GLMD) shares are trading with a volume of 0, against a daily average of 66.32K.

In the last year, Galmed Pharmaceuticals(GLMD) shares hit a 52-week high of $3.50 and a 52-week low of $0.59.

In the last year, Galmed Pharmaceuticals(GLMD) shares hit a 52-week high of $3.50 and a 52-week low of $0.59.

People also own

Based on the portfolios of people who own GLMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.